Physician diagnosis of asthma requiring a controller treatment with ICS or ICS/Long-acting beta-agonists (LABA) via MDI
Partly controlled or uncontrolled asthma based on GINA criteria and definitions
Informed consent signed by legally authorized representatives (LAR) and assent from young patient (only applicable for children ≥ 10 years)
You may not be if
Patients with severe asthma exacerbation treated with systemic corticosteroids within the last 2 weeks or patients with active respiratory tract infection
Diagnosis of underlying chronic lung disease other than asthma (e.g., BPCO/cystic fibrosis etc.)
Severe asthma based on GINA definitions
Severe underlying disorders ((severe congenital heart disease, oncologic patients) (non-exhaustive list, left to the evaluation of the PI))
Immune deficiency or under immunosuppressive treatments
In receipt of immunotherapy (only for participants in Luxembourg donating samples for biomarker research)
Patients with neurological diseases / impaired cognitive disorder
Siblings of patients already included in the study
Clareo Health | Advancing Diagnosis and Treatment of Pediatric Asthma
